{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:07:38Z","timestamp":1788196058837,"version":"build-2803163510"},"reference-count":36,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Patients in cardiogenic shock (CS) often require prolonged mechanical circulatory support lasting longer than 14 days. Prolonged support with Impella 5.5 can improve outcomes in these patients. Here, we describe our experience with prolonged Impella 5.5 support. Methods: From January 2023 to June 2024, 64 patients receiving Impella 5.5 support for more than 14 days were identified. Information including demographics, heart failure etiology, and hospital course were collected. Results: Of the 64 patients identified, 54 were male, with an average age of 55.9 years. One patient was classified as SCAI class C, 41 as SCAI class D, and 22 as SCAI class E. Heart failure etiologies included 41 patients with non-ischemic cardiomyopathy, 10 with ischemic cardiomyopathy, 10 with acute myocardial infarction, 1 with cardiac allograft rejection, 1 with post-cavotricuspid isthmus ablation, and 1 with post-cardiotomy (aortic root replacement) CS. The average duration of Impella 5.5 support was 27.1 days. Escalation to Impella 5.5 was observed in 26 patients, with 15 having escalated from intra-aortic balloon pump and 11 from Impella CP. Overall survival, including heart recovery, orthotopic heart transplantation (OHT), or left ventricular assist device (LVAD), was 81.3% (52\/64) in patients with Impella 5.5. Patients were discharged after OHT (27\/64), cardiac recovery (13\/64), or durable LVAD placement (12\/64), and 12 patients expired. Conclusions: Our data suggest that Impella 5.5 provides durable support for patients beyond the 14-day period currently approved by the FDA for CS management. Further evaluation of long-term Impella 5.5 support for cardiac recovery or as a bridge to advanced therapies should be considered.<\/jats:p>","DOI":"10.3390\/jcm14165631","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:30:52Z","timestamp":1754667052000},"page":"5631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prolonged Impella 5.5 Support in Patients with Cardiogenic Shock: A Single-Center Retrospective Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6337-6582","authenticated-orcid":false,"given":"Ioana","family":"Dumitru","sequence":"first","affiliation":[{"name":"Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"DeWolf","sequence":"additional","affiliation":[{"name":"Alabama College of Osteopathic Medicine, Dothan, AL 36303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sevillano","sequence":"additional","affiliation":[{"name":"Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeeAndra","family":"Schnell","sequence":"additional","affiliation":[{"name":"Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram","family":"Bezerra","sequence":"additional","affiliation":[{"name":"Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Rinde-Hoffman","sequence":"additional","affiliation":[{"name":"Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Savarese, G., and Lund, L.H. (2017). Global Public Health Burden of Heart Failure. Card. Fail. Rev., 3.","DOI":"10.15420\/cfr.2016:25:2"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Al Hazzouri, A., Attieh, P., Sleiman, C., Hamdan, R., Ghadieh, H.E., and Harbieh, B. (2024). Left Ventricular Assist Device in Advanced Refractory Heart Failure: A Comprehensive Review of Patient Selection, Surgical Approaches, Complications and Future Perspectives. Diagnostics, 14.","DOI":"10.3390\/diagnostics14222480"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jung, R.G., Stotts, C., Gupta, A., Prosperi-Porta, G., Dhaliwal, S., Motazedian, P., Abdel-Razek, O., Di Santo, P., Parlow, S., and Belley-Cote, E. (2024). Prognostic Factors Associated with Mortality in Cardiogenic Shock\u2014A Systematic Review and Meta-Analysis. NEJM Evid., 3.","DOI":"10.1056\/EVIDoa2300323"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.hfc.2021.06.002","article-title":"Advanced Heart Failure","volume":"17","year":"2021","journal-title":"Heart Fail. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pieri, M., Ortalda, A., Altizio, S., Bertoglio, L., Nardelli, P., Fominskiy, E., Lapenna, E., Ajello, S., and Scandroglio, A.M. (2024). Prolonged Impella 5.0\/5.5 support within different pathways of care for cardiogenic shock: The experience of a referral center. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1379199"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.21037\/jtd-21-832","article-title":"Bridge to transplantation from mechanical circulatory support: A narrative review","volume":"13","author":"Zhou","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jchf.2020.03.010","article-title":"Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis","volume":"8","author":"Jawitz","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Alkhunaizi, F.A., Smith, N., Brusca, S.B., and Furfaro, D. (2024). The Management of Cardiogenic Shock from Diagnosis to Devices: A Narrative Review. CHEST Crit. Care, 2.","DOI":"10.1016\/j.chstcc.2024.100071"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/eurheartjsupp\/suaf002","article-title":"The role of temporary mechanical circulatory support in heart failure","volume":"27","author":"Vandenbriele","year":"2025","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2023.01.011","article-title":"Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients","volume":"42","author":"Ramzy","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Parry, S.M., and Puthucheary, Z.A. (2015). The impact of extended bed rest on the musculoskeletal system in the critical care environment. Extrem. Physiol. Med., 4.","DOI":"10.1186\/s13728-015-0036-7"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rock, J.R., Kos, C.A., Lemaire, A., Ikegami, H., Russo, M.J., Moin, D., Dulnuan, K., and Iyer, D. (2022). Single center first year experience and outcomes with Impella 5.5 left ventricular assist device. J. Cardiothorac. Surg., 17.","DOI":"10.1186\/s13019-022-01871-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E158","DOI":"10.1097\/MAT.0000000000001796","article-title":"Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients","volume":"69","author":"Zaky","year":"2022","journal-title":"ASAIO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MAT.0000000000001931","article-title":"Extended Support with the Impella 5.5: Transplant, ECMO, and Complications","volume":"69","author":"Cohen","year":"2023","journal-title":"ASAIO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/15569845231196862","article-title":"Surgical Explantation of Impella 5.5 With Inflow Thrombus in Patients Undergoing Durable Left Ventricular Assist Device Implantation","volume":"18","author":"Marcano","year":"2023","journal-title":"Innov. Technol. Tech. Cardiothorac. Vasc. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/15569845231212157","article-title":"Reconsidering FDA Guidelines: A Single-Center Experience of Prolonged Impella 5.5 Support","volume":"19","author":"Valdes","year":"2024","journal-title":"Innov. Technol. Tech. Cardiothorac. Vasc. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1111\/jocs.16038","article-title":"Successful use of Impella 5.5 to manage cardiogenic shock complicated by COVID-19","volume":"36","author":"Mahrokhian","year":"2021","journal-title":"J. Card. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sharaf, O.M., Diaz-Ayllon, H.P., Myers, E.M., Ahmed, M.M., Bleiweis, M.S., and I Jeng, E. (2023). Successful extended use of Impella 5.5 as a bridge to heart transplantation. J. Surg. Case Rep., 2023.","DOI":"10.1093\/jscr\/rjad262"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MAT.0000000000002296","article-title":"Extended Duration of Impella 5.5 Support Does Not Adversely Impact Outcomes Following Heart Transplantation: A National Registry Analysis","volume":"71","author":"Hong","year":"2024","journal-title":"ASAIO J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Everett, K.D., Jain, P., Botto, R., Salama, M., Miyashita, S., Reyelt, L., Kawabori, M., and Kapur, N.K. (2021). Acute Effects of Left Ventricular Support with Impella 5.5 on Biventricular Hemodynamics. Circ. Heart Fail., 14.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008616"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Suzuki, T., and Sugiura, R. (2023). Improvement of persistent anuria in severe myocardial infarction: The potential role of Impella 5.5 as a bridge to decision. BMJ Case Rep., 16.","DOI":"10.1136\/bcr-2023-255462"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transproceed.2023.10.006","article-title":"Minimally Invasive Direct Aortic Implantation of Impella 5.5 As Bridge to Transplant: A Case Report","volume":"56","author":"Dichiacchio","year":"2024","journal-title":"Transplant. Proc."},{"key":"ref_24","unstructured":"Karner, B., Arnreiter, M., Zirngast, B., Pavlikova, M., Renz, D., Yates, A., and Zimpfer, D. (2023). Subclavian Impella 5.5 implant for perioperative left ventricular dysfunction. Multimed. Man. Cardiothorac Surg., 2023."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/MAT.0000000000002193","article-title":"Impella 5.5 Bridge to Heart Transplant: An Institutional Series and a Closer Look at Device Removal Technique","volume":"70","author":"Clothier","year":"2024","journal-title":"ASAIO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jocs.16256","article-title":"Triple therapy temporary mechanical circulatory support as a bridge to triple-organ transplantation","volume":"37","author":"Sharaf","year":"2022","journal-title":"J. Card. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kawabori, M., Nordan, T., and Kapur, N.K. (2020). Purge Sidearm Damage: Achilles Heel of New Surgical Circulatory Support System?. ASAIO J., 67.","DOI":"10.1097\/MAT.0000000000001241"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kanwar, M.K., Uriel, N., Carnicelli, A., John, K., Li, S., Kong, C., Zweck, E., Sinha, S.S., Ton, V.K., and Garan, A.R. (2025). Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis. J. Heart Lung Transplant., 29.","DOI":"10.1016\/j.healun.2025.05.017"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Panuccio, G., Neri, G., Macr\u00ec, L.M., Salerno, N., De Rosa, S., and Torella, D. (2022). Use of Impella device in cardiogenic shock and its clinical outcomes: A systematic review and meta-analysis. IJC Heart Vasc., 40.","DOI":"10.1016\/j.ijcha.2022.101007"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock","volume":"390","author":"Jensen","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Basir, M.B., Lemor, A., Gorgis, S., Patel, K.C., Kolski, B.C., Bharadwaj, A.S., Todd, J.W., Tehrani, B.N., Truesdell, A.G., and Lasorda, D.M. (2023). Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative. J. Am. Heart Assoc., 12.","DOI":"10.1161\/JAHA.123.031401"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2022.08.032","article-title":"Impella versus intra-aortic balloon pump for high-risk PCI: A propensity-adjusted large-scale claims dataset analysis","volume":"185","author":"Lansky","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vora, N., Chaudhary, R., Upadhyay, H.V., Konat, A., Zalavadia, P., Padaniya, A., Patel, P., Patel, N., Prajjwal, P., and Sharma, K. (2023). Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock. Cureus, 15.","DOI":"10.7759\/cureus.33372"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MAT.0000000000002170","article-title":"Prehabilitation Maximizing Functional Mobility in Patients with Cardiogenic Shock Supported on Axillary Impella","volume":"70","author":"Bhardwaj","year":"2024","journal-title":"ASAIO J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E251","DOI":"10.1097\/MAT.0000000000001712","article-title":"Surgically Implanted Impella Device for Patients on Impella CP Support Experiencing Refractory Hemolysis","volume":"68","author":"Bergeron","year":"2022","journal-title":"ASAIO J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tonleu, F.H.A., Zapata, D., Daneshmand, M., Staloch, D., and Agrawal, A. (2022). Outcomes with Impella 5.0 and 5.5 in Cardiogenic Shock. J. Card. Fail., 28.","DOI":"10.1016\/j.cardfail.2022.03.183"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:59Z","timestamp":1760034419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":36,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165631"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165631","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}